elanco animal health inc posted lower thirdquarter sales as supply constraints and worsening economic conditions weighed on the companys results the greenfield indbased developer and manufacturer of pet and farmanimal products said its net loss was 49 million or 10 cents a share compared with a net loss of 104 million or 21 cents a share a year earlier stripping out onetime items including amortization and restructuring costs adjusted earnings came to 20 cents a share analysts polled by factset were forecasting adjusted earnings of 16 cents a share revenue for the quarter ended sept 30 fell 9 to 103 billion matching wall street expectations the company said sales volume declined in its pethealth business because of worsening global economic conditions affected parasiticide products in europe and us retail channels as well as competitive pressure on certain parasiticide products in the farmanimal business supply constraints of certain us cattle vaccines and a decline for swine in international markets particularly in asia offset higher demand for poultry products it said write to will feuer at willfeuerwsjcom